Why the study?
It was unclear whether catheter ablation for atrial fibrillation affects long-term prognosis in elderly patients.
Does catheter ablation reduce mortality, stroke/TIA, and cardiovascular hospitalization in patients >75 years old with non-valvular atrial fibrillation?
Does catheter ablation reduce mortality, stroke/TIA, and cardiovascular hospitalization in patients >75 years old with non-valvular atrial fibrillation?
In elderly patients (>75 years) with non-valvular atrial fibrillation, catheter ablation may be associated with reduced all-cause and cardiovascular mortality.
CA may link to lower mortality in elderly AF; leaves open causal benefit pending randomized confirmation.
BACKGROUND: It is unclear whether catheter ablation (CA) for atrial fibrillation (AF) affects the long-term prognosis in the elderly. This study aims to evaluate the relationship between CA and long-term outcomes in elderly patients with AF. METHODS: Patients more than 75 years old with non-valvular AF were prospectively enrolled between August 2011 and December 2017 in the Chinese Atrial Fibrillation Registry Study. Participants who underwent CA at baseline were propensity score matched (1:1) with those who did not receive CA. The outcome events included all-cause mortality, cardiovascular mortality, stroke/transient ischemic attack (TIA), and cardiovascular hospitalization. RESULTS: = 0.1084). Subgroup analyses according to gender, type of AF, time since onset of AF, and anticoagulants exposure in initiation did not show significant heterogeneity. CONCLUSIONS: In elderly patients with AF, CA may be associated with a lower incidence of all-cause and cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
Su et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: